|
ATGA0499-50ul
|
NKMax Bio (ATGen)
|
HA Tag [AT5E7], Mouse Monoclonal Antibody
|
|
ELISA, WB
|
|
|
ATGA0395-100ul
|
NKMax Bio (ATGen)
|
Myc tag [AT19B4], Mouse Monoclonal Antibody
|
Human
|
ELISA, WB
|
|
|
ATGA0395-50ul
|
NKMax Bio (ATGen)
|
Myc tag [AT19B4], Mouse Monoclonal Antibody
|
Human
|
ELISA, WB
|
|
|
HY-P80229-10uL
|
MedChemexpress LLC
|
Mre11 Antibody
|
|
|
|
|
HY-P80229-100uL
|
MedChemexpress LLC
|
Mre11 Antibody
|
|
|
|
|
HY-P80229-50uL
|
MedChemexpress LLC
|
Mre11 Antibody
|
|
|
|
|
HY-108507-1mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
|
HY-108507-10mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
|
HY-108507-25mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
|
HY-108507-5mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
|
HY-108507-50mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
|
HY-108507-1mL
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-134813-1mg
|
MedChemexpress LLC
|
MRTX1133 [CAS 2621928-55-8]
|
|
|
|
|
HY-134813-10mg
|
MedChemexpress LLC
|
MRTX1133 [CAS 2621928-55-8]
|
|
|
|
|
HY-134813-5mg
|
MedChemexpress LLC
|
MRTX1133 [CAS 2621928-55-8]
|
|
|
|
|
HY-134813-1mL
|
MedChemexpress LLC
|
MRTX1133 [CAS 2621928-55-8] (10mM in DMSO)
|
|
|
|
|
HY-P80758-10uL
|
MedChemexpress LLC
|
MSR1 Antibody
|
|
|
|
|
HY-P80758-100uL
|
MedChemexpress LLC
|
MSR1 Antibody
|
|
|
|
|
HY-P80758-50uL
|
MedChemexpress LLC
|
MSR1 Antibody
|
|
|
|
|
HY-P80230-10uL
|
MedChemexpress LLC
|
Mst2 Antibody
|
|
|
|
|
HY-P80230-100uL
|
MedChemexpress LLC
|
Mst2 Antibody
|
|
|
|
|
HY-P80230-50uL
|
MedChemexpress LLC
|
Mst2 Antibody
|
|
|
|
|
HY-126077-1mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-126077-10mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-126077-100mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
